KSE - Delayed Quote KRW
Hanmi Pharm. Co., Ltd. (128940.KS)
265,500.00
-3,500.00
(-1.30%)
At close: May 2 at 3:30:14 PM GMT+9
Research Analysis
Earnings Estimate
| Currency in KRW | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 9 | 14 |
| Avg. Estimate | 35.7 | 0 | 12,396.67 | 12,793.89 |
| Low Estimate | 35.7 | 0 | 11,103 | -5,642 |
| High Estimate | 35.7 | 0 | 13,668.06 | 17,764.33 |
| Year Ago EPS | -- | -- | 9,567 | 12,396.67 |
Revenue Estimate
| Currency in KRW | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 11 | 14 |
| Avg. Estimate | 399.1B | 401.18B | 1.62T | 1.75T |
| Low Estimate | 395B | 386.1B | 1.6T | 1.68T |
| High Estimate | 403B | 420.3B | 1.66T | 1.84T |
| Year Ago Sales | 378.13B | 362.08B | 1.5T | 1.2T |
| Sales Growth (year/est) | 5.54% | 10.80% | 8.13% | 45.76% |
Earnings History
| Currency in KRW | 3/31/2025 |
|---|---|
| EPS Est. | 38.2 |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| Currency in KRW | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 35.7 | 0 | 12,396.67 | 12,793.89 |
| 7 Days Ago | 35.7 | 0 | 11,465.32 | 12,701.12 |
| 30 Days Ago | 0 | 0 | 12,633.26 | 13,910.74 |
| 60 Days Ago | 0 | 0 | 12,743.53 | 14,000.55 |
| 90 Days Ago | 0 | 0 | 13,381.58 | 15,224.84 |
EPS Revisions
| Currency in KRW | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 3 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 128940.KS | -- | -- | 29.58% | 3.20% |
| S&P 500 | 12.47% | 3.19% | 8.01% | 13.87% |